Compare ENLV & HERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENLV | HERE |
|---|---|---|
| Founded | 2005 | 2019 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.3M | 296.4M |
| IPO Year | 2014 | N/A |
| Metric | ENLV | HERE |
|---|---|---|
| Price | $1.14 | $4.71 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 336.3K | 103.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $47.96 |
| P/E Ratio | ★ N/A | $2.83 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $3.82 |
| 52 Week High | $2.10 | $5.80 |
| Indicator | ENLV | HERE |
|---|---|---|
| Relative Strength Index (RSI) | 57.00 | 55.61 |
| Support Level | $1.00 | $4.38 |
| Resistance Level | $1.23 | $5.72 |
| Average True Range (ATR) | 0.07 | 0.26 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 56.00 | 90.10 |
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.